FDA Issues Warning of Cancer Risk Tied to CAR-T Therapies
The agency has reviewed reports of cancer patients whose treatments resulted in the development of secondary blood cancers. Several companies will be required to carry the new warning.
Stay updated with breaking news from John Dipersio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The agency has reviewed reports of cancer patients whose treatments resulted in the development of secondary blood cancers. Several companies will be required to carry the new warning.
More states are barring the practice of white bagging, while oncology groups and insurance advocates continue to debate its impacts on costs.
Scientists are devising ways to edit the genomes of immune cells without having to extract them from those being treated. Scientists are devising ways to edit the genomes of immune cells without having to extract them from those being treated.
The FDA announced that certain CAR-T treatments for blood cancer have been linked to the development of other cancers.
The agency is looking into reports that some patients developed new blood cancers after receiving CAR-T treatments.